Description of the first epidemic curve due to Covid-19 in Costa Rica
PDF (Español (España))
HTML (Español (España))
AUDIO (Español (España))

Keywords

Covid-19
epidemiology
Costa Rica

How to Cite

1.
Rodriguez Herrera R, Victor Mora E, Valverde Gallegos R. Description of the first epidemic curve due to Covid-19 in Costa Rica. Rev Ter [Internet]. 2021 Jan. 27 [cited 2026 Apr. 1];15(1):96-106. Available from: https://www.revistaterapeutica.net/index.php/RT/article/view/114

Abstract

Introduction: the objective of this manuscript was to describe the main epidemiological characteristics of the so-called first epidemic curve caused by the Covid-19 disease in Costa Rica between March 6 and April 24, 2020.  Results: at the end of those 50 days of the first curve, there were a total of 687 confirmed patients, between the ages of 1 and 87, 52% male (n = 359), affecting 0.013% of the country's registered inhabitants (n: 5 111 238) with a lethality of 0.87%. The average number of new cases per day was 13.8, the median was 16, and the mode was 19. 90% of the cases were nationals (n = 620) and 10% (n = 67) were foreigners, including formal residents. The age distribution was 91% of adult patients (n = 618), 5.1% of older adults (n = 35) and 4.9% of minors (n = 34). During the first epidemic curve, it was possible to monitor the cases and establish the clusters, which facilitated the work of care by health personnel.  Conclusion: unlike other countries, the first epidemic curve in Costa Rica represented a particular period of low stress (few cases and low lethality of these) for the national health system, which could be used to strengthen interventions in at-risk communities potential, such as human settlements located in border plantations, slums and barracks, and also to reinforce health education in the population, as well as provide the health system with more resources to attend the second epidemic wave.

https://doi.org/10.33967/rt.v15i1.128
PDF (Español (España))
HTML (Español (España))
AUDIO (Español (España))

References

Organización Mundial de la Salud. Coronavirus disease 2019 (COVID-19) Situation Report –94 [Internet]. Ginebra: OMS; 2020. Disponible en: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200423-sitrep-94-covid-19.pdf

Yin C. Genotyping coronavirus SARS-CoV-2: methods and implications. Genomics. 2020;112(5):3588-3596. doi: 10.1016/j.ygeno.2020.04.016.

Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020 19;91(1):157-160. doi: 10.23750/abm.v91i1.9397

Adhamon T. Organización Mundial de la Salud [Internet]. Ginebra: OMS; 2020. WHO: Director-General's opening remarks at the media briefing on COVID19 -March 2020; [aprox. 5 pantallas]. Disponible en: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020

Huang Y, Yang C, Xu XF, Xu W, Liu SW. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin. 2020;41(9):1141-1149. doi: 10.1038/s41401-020-0485-4.

Virological [Internet]. Reino Unido: Virological.org; 2020. Novel 2019 Coronavirus Genome. Disponible en: https://virological.org/t/novel-2019-coronavirus-genome/319

Du Toit A. Outbreak of a novel coronavirus. Nat Rev Microbiol. 2020;18(3):123. doi: 10.1038/s41579-020-0332-0

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-273. doi: 10.1038/s41586-020-2012-7

Lam TT, Jia N, Zhang YW, Shum MH, Jiang JF, Zhu HC, et al. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature. 2020;583(7815):282-285. doi: 10.1038/s41586-020-2169-0.

Munnink BBO, Sikkema RS, Nieuwenhuijse DF, Molenaar RJ, Munger E, Molenkamp R, et al. Jumping back and forth: anthropozoonotic and zoonotic transmission of SARS-CoV-2 on mink farms. BioRxiv. 2020. doi: 10.1101/2020.09.01.277152v1

Chen J. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect. 2020;22(2):69-71. doi: 10.1016/j.micinf.2020.01.004

Organización Mundial de la Salud. Transmisión del SARS-CoV-2: repercusiones sobre las precauciones en materia de prevención de infecciones [Internet]. Ginebra: OMS; 2020. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/333390/WHO-2019-nCoV-Sci_Brief-Transmission_modes-2020.3-spa.pdf

Organización Mundial de la Salud [Internet]. Ginebra: OMS; 2020. Vías de transmisión del virus de la COVID-19: repercusiones para las recomendaciones relativas a las precauciones en materia de prevención y control de las infecciones; [aprox. 8 pantallas]. Disponible en: https://www.who.int/es/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations

Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9(1):29. doi: 10.1186/s40249-020-00646-x.

Organización Panamericana de la Salud. Módulo de Principios de Epidemiología para el Control de Enfermedades (MOPECE). Unidad 4: Vigilancia en Salud Pública [Internet]. 2a ed. Washington: OPS; 2011. Disponible en: https://www.paho.org/col/index.php?option=com_docman&view=download&category_slug=publicaciones-ops-oms-colombia&alias=856-mopece4&Itemid=688

Caja Costarricense del Seguro Social [Internet]. San José: CCSS; 2020. COVID-19; [aprox. 5 pantallas]. Disponible en: https://www.ccss.sa.cr/web/coronavirus/index

Ministerio de Salud (CR) [Internet]. San José, CR: Ministerio de Salud; 2020. Situación Nacional Covid-19; [aprox. 6 pantallas]. Disponible en: https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/741-noticias-2020/1725-situacion-nacional-covid-19

Caja Costarricense del Seguro Social [Internet]. San José: CCSS; 2020. Enfermedad Covid19 por el nuevo coronavirus; [aprox. 5 pantallas]. Disponible en: https://www.ccss.sa.cr/web/coronavirus/?gclid=EAIaIQobChMIqai4xM_G7QIVxDizAB2DsgmHEAAYASAAEgI-xPD_BwE

Gobierno de México [Internet]. México: Gobierno de México; 2020. Coronavirus. Disponible en: https://coronavirus.gob.mx/

Universidad de Costa Rica, Centro Centroamericano de Población [Internet]. San José, CR: Centro Centroamericano de Población; 2020. Tasa R Covid-19; [aprox. 10 pantallas]. Disponible en: https://ccp.ucr.ac.cr/index.php/tasa-r-covid-19.html

Ministerio de Salud (CR) [Internet]. San José, CR: Ministerio de Salud; 2020. 687 casos confirmados por COVID-19; [aprox. 1 pantalla]. Disponible en: https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/741-noticias-2020/1630-687-casos-confirmados-por-covid-19

Instituto Nacional de Estadística y Censos (CR) [Internet]. San José, CR: INEC; 2020. Proyección de Población al 30 de junio de 2020; [aprox. 1 pantalla]. Disponible en: https://www.inec.cr/

Ministerio de Salud (CR) [Internet]. San José, CR: Ministerio de Salud; 2020. Situación Nacional COVID-19 : 24 Abril 2020; [aprox. 1 pantalla]. Disponible en: https://geovision.uned.ac.cr/oges/historico_covid/covid19_20200424.html

Bustamante Castillo X. Caja Costarricense del Seguro Social [Internet]. San José: CCSS; 2020. Mayor esfuerzo en acatar medidas sanitarias puede frenar velocidad de transmisión y mantener capacidad en servicios de salud; [aprox. 6 pantallas]. Disponible en: https://www.ccss.sa.cr/noticias/servicios_noticia?mayor-esfuerzo-en-acatar-medidas-sanitarias-puede-frenar-velocidad-de-transmision-y-mantener-capacidad-en-servicios-de-salud

Rodríguez E. CCSS dispone de 912 respiradores y 211 camas UCI para atender pacientes con COVID-19 [Internet]. El Observador. 01 de setiembre de 2020. Disponible en: https://observador.cr/noticia/ccss-dispone-de-912-respiradores-y-211-camas-uci-para-atender-pacientes-con-covid-19/

Aguilar Ramírez P, Enríquez Valencia Y, Quiroz Carrillo C, Valencia Ayala E, de León Delgado J, Pareja Cruz A. Pruebas diagnósticas para la COVID-19: la importancia del antes y el después. Horiz. Med [Internet]. 2020;20(2):e1231. doi: 10.24265/horizmed.2020.v20n2.14

Duarte Martínez F, Molina Mora JA, Cordero Laurent E, Godínez Rojas A, Calderón Osorno M, Corrales Aguilar E, et al. Análisis genómico de secuencias del virus SARS-CoV-2 de casos costarricenses [Internet]. San José, CR: Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud; 2020. Disponible en: https://www.inciensa.sa.cr/vigilancia_epidemiologica/informes_vigilancia/2020/Virologia/20200910_SARS-CoV-2_wgs_informev2.pdf

Datosmacro [Internet]. España: Datosmacro; 2020. Panamá - COVID-19 - Crisis del coronavirus; [aprox. 5 pantallas]. Disponible en: https://datosmacro.expansion.com/otros/coronavirus/panama

Padilla Santamaría F, Maya Franco L, Ferman Cano F. COVID-19 en México: Panorama Epidemiológico. Rev Cadena Cereb. 2020;4(1):31-42. doi: 10.5281/zenodo.3926806

Centers for Disease Control and Prevention (US) [Internet]. Atlanta: CDC; 2020. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19; [aprox. 9 pantallas]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html

Bchetnia M, Girard C, Duchaine C, Laprise C. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status. J Infect Public Health. 2020;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Copyright (c) 2021 Robinson Rodriguez Herrera, Enrique Victor Mora, Rocío Valverde Gallegos

Downloads

Download data is not yet available.